此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

评估树脂基与生物陶瓷封闭剂在无症状根尖周炎下颌磨牙术后疼痛的应用效果

2026年11月14日 更新者:AZİZ ŞAHİN ERDOĞAN

评估树脂基与生物陶瓷封闭剂对单次就诊治疗无症状根尖周炎下颌磨牙术后疼痛的影响

The goal of this clinical trial is to compare two root canal sealers in adults who need root canal treatment of a lower back tooth (mandibular first or second molar) with a dead (necrotic) pulp and no pain before treatment. The main question it aims to answer is: Does the type of sealer used to fill the root canals affect pain after single-visit root canal treatment?

Researchers compared a calcium silicate-based sealer (BioRoot RCS) with an epoxy resin-based sealer (AH Plus).

Participants:

Received root canal treatment completed in a single visit, with canals filled using the cold lateral compaction technique and one of the two sealers, assigned at random Recorded their pain on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7 after treatment Recorded whether, when, and how much pain medication (ibuprofen) they took during the 7-day follow-up

研究概览

详细说明

This single-center, parallel-group randomized controlled trial was conducted at the Department of Endodontics, Faculty of Dentistry, Atatürk University (Erzurum, Türkiye). Seventy patients with a mandibular first or second molar with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (periapical index score ≤ 3), without preoperative pain, were randomly allocated in a 1:1 ratio to the BioRoot RCS group or the AH Plus group (35 per group).

All treatments were performed in a single visit by one operator following a standardized protocol. Canals were shaped with the WaveOne Gold reciprocating system and irrigated with 2.5% sodium hypochlorite, followed by final irrigation with 17% EDTA, 2.5% sodium hypochlorite, and saline. Allocation was concealed in sequentially numbered, opaque, sealed envelopes opened immediately before obturation. In both groups, canals were obturated by cold lateral compaction, and the teeth were permanently restored in the same visit.

The primary outcome was postoperative pain intensity on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7. The secondary outcome was the proportion of participants who used rescue analgesics (ibuprofen 400 mg) during the 7-day follow-up.

研究类型

介入性

注册 (实际的)

70

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • palandöken
      • Erzurum、palandöken、土耳其(türkiye)、25100
        • Atatürk University Faculty of Dentistry

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Age 18-65 years
  • American Society of Anesthesiologists (ASA) physical status I
  • Mandibular first or second molar with complete root formation and no previous endodontic treatment
  • Pulp necrosis (no response to cold and electric pulp tests), confirmed clinically by the absence of bleeding in the pulp chamber during access cavity preparation
  • Normal apical tissues or asymptomatic apical periodontitis according to the American Association of Endodontists diagnostic terminology (periapical index score of 3 or less)
  • No spontaneous pain and no tenderness to percussion or palpation before treatment
  • No analgesic intake within the previous 72 hours and no antibiotic intake within the previous month
  • Written informed consent

Exclusion Criteria:

  • Systemic disease, immunodeficiency, or regular medication use
  • Pregnancy
  • Known allergy to the materials or drugs used in the study
  • Symptomatic apical periodontitis, acute apical abscess, or chronic apical abscess
  • Swelling or sinus tract
  • Periodontal probing depth greater than 3 mm
  • Root canal calcification, internal or external root resorption, or open apex
  • Teeth requiring a post-and-core restoration
  • Periapical index score greater than 3
  • Bleeding in the pulp chamber during access cavity preparation (pulp necrosis not confirmed)
  • Two canals in the distal root
  • Treatment that could not be completed in a single visit or that required intracanal medication

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:BioRoot RCS Group

Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the calcium silicate-based sealer BioRoot RCS.

Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the calcium silicate-based sealer BioRoot RCS (Septodont). No intracanal medication was used.

有源比较器:AH Plus Group

Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the epoxy resin-based sealer AH Plus.

Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the epoxy resin-based sealer AH Plus (Dentsply DeTrey). No intracanal medication was used.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Postoperative pain intensity
大体时间:6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment

Postoperative pain intensity was self-recorded by participants on a 100 mm visual analog scale (VAS), where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain. VAS scores were categorized as no pain (0-4 mm), mild (5-34 mm), moderate (35-64 mm), severe (65-85 mm), and very severe pain (86-100 mm), and the groups were compared at each time point.

6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment

次要结果测量

结果测量
措施说明
大体时间
Proportion of participants using analgesics
大体时间:From the end of treatment to day 7 after treatment

Proportion of participants in each group who took rescue analgesic medication (ibuprofen 400 mg, taken only in case of severe pain) during the follow-up period, as self-recorded on the pain record form together with the time and dose of each intake.

From the end of treatment to day 7 after treatment

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年3月12日

初级完成 (实际的)

2025年10月2日

研究完成 (实际的)

2025年10月2日

研究注册日期

首次提交

2025年12月2日

首先提交符合 QC 标准的

2025年12月15日

首次发布 (实际的)

2025年12月17日

研究记录更新

最后更新发布 (实际的)

2026年11月17日

上次提交的符合 QC 标准的更新

2026年11月14日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅